ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,860.00
0.49%
S&P ASX All Technology
3,102.60
0.47%
Brent Oil
79.395
0.00%
US Dollar vs AUD
1.51653
-0.06%
Bitcoin
69,337.84
0.00%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Neurochem - Common Shares (MM) (NRMX)

  7. Neurochem - Common Shares (MM) (NRMX) News

NRMX

Neurochem (NRMX)

Neurochem - Common Shares (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NRMX
DateTimeSourceHeadlineSymbolCompany
17/04/200801:57Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
15/04/200822:00PR Newswire (US)At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update oNASDAQ:NRMX
12/04/200806:27Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
12/04/200804:30PR Newswire (US)Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008NASDAQ:NRMX
12/04/200802:24PR Newswire (US)Neurochem Annual and Special Meeting of shareholdersNASDAQ:NRMX
11/04/200801:26Edgar (US Regulatory)Neurochem Inc - Amended Annual Report (foreign private issuer) (40-F/A)NASDAQ:NRMXNeurochem - Common Shares (MM)
21/03/200803:48Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
15/03/200808:23Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
15/03/200808:07Edgar (US Regulatory)Neurochem Inc - Annual Report (foreign private issuer) (40-F)NASDAQ:NRMXNeurochem - Common Shares (MM)
14/03/200806:25Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
13/03/200822:00PR Newswire (US)Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosisNASDAQ:NRMX
23/02/200806:10Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
22/02/200811:19PR Newswire (US)Neurochem announces departure of two members of management teamNASDAQ:NRMX
22/02/200808:54Edgar (US Regulatory)Neurochem Inc - Amended Report of Foreign Issuer (6-K/A)NASDAQ:NRMXNeurochem - Common Shares (MM)
22/02/200807:18Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
21/02/200811:12PR Newswire (US)Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectivesNASDAQ:NRMX
16/02/200807:45Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
14/02/200804:26PR Newswire (US)/C O R R E C T I O N from source -- Neurochem Inc./NASDAQ:NRMX
12/02/200807:55Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
12/02/200802:46PR Newswire (US)Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast liveNASDAQ:NRMX
31/01/200808:26Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
31/01/200800:00PR Newswire (US)Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical businessNASDAQ:NRMX
04/01/200807:59Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
04/01/200805:08PR Newswire (US)Neurochem to present at JPMorgan Healthcare ConferenceNASDAQ:NRMX
15/12/200707:51Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
15/12/200700:24PR Newswire (US)Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosisNASDAQ:NRMX
08/12/200709:25Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
07/12/200709:09PR Newswire (US)Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 reviewNASDAQ:NRMX
04/12/200707:05Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
01/12/200708:15PR Newswire (US)Neurochem announces departure of Dr. Philippe Calais, President, Global BusinessNASDAQ:NRMX
 Showing the most relevant articles for your search:NASDAQ:NRMX

Your Recent History

NASDAQ
AAPL
Apple
ASX
WDC
Westfield
ASX
AMP
AMP
ASX
FMG
Fortescue
ASX
WPL
Woodside Petroleum
COIN
ETHUSD
Ethereum
ASX
XTO
S&P ASX 100
ASX
CSL
CSL
NYSE
VZ
Verizon Communications
CCOM
SILVER
SILVER
FTSE
UKX
FTSE 100
NYSE
NKE
Nike
FX
GBPAUD
Sterling vs AUD
NASDAQ
MSFT
Microsoft
ASX
WOW
Woolworths
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved